NEW YORK (GenomeWeb) – Sure Genomics announced today that it has signed a deal to offer Sanitas' Family Healthware health risk assessment application to its customers.
Family Healthware is a 510(k) service approved by the US Food and Drug Administration to identify a person's familial risk for heart disease, stroke, diabetes, and colorectal, breast, and ovarian cancers based on a questionnaire that collects health data, behaviors, recent lab tests, and family medical history.
"Sanitas is committed to helping people better understand their health risk factors, which is a focus we share," Sure Genomics Founder and CEO said in a statement. "Together, we offer consumers and their healthcare providers reliable disease risk information, and can incorporate genetic information to help people make more informed decisions about their personal health."
Specific terms of the deal were not disclosed.